{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:36:17Z","timestamp":1757612177235,"version":"3.44.0"},"reference-count":29,"publisher":"Institute of Biochemistry","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BIOMED KHIM"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Immune thrombocytopenia (ITP) is one of the most common causes of decreased platelet count. Bleeding is the main clinical symptom of ITP; although its severity correlates with the depth of thrombocytopenia, it may also depend on changes in the functional activity of platelets. In this study we have compared platelet functional activity in healthy volunteers (HV) and in ITP patients, as well as in groups of ITP patients with different levels of bleeding. The study included 65 HV and 84 ITP patients. Platelet activity was assessed by flow cytometry. Platelets were activated with thrombin receptor activating peptide (TRAP) or ADP, and the exposure of activation markers, activated form of glycoprotein (GP) IIb-IIIa and alpha-granule membrane protein P-selectin, was determined on their surface by measuring the binding of PAC-1 and CD62P antibodies, respectively. Platelet-associated IgG (PA-IgG, an indicator of the level of antiplatelet autoantibodies), the percentage of \u201cyoung\u201d reticular platelets (RP, %) and platelet light scatter (an indicator of their size) were also assessed using flow cytofluorimetry. Platelet binding of PAC-1 (and, to a lesser extent, CD62P binding) was lower in ITP patients than in HV. In ITP patients, PAC-1 binding inversely correlated with the PA-IgG content. In contrast to HV, in ITP patients, PAC-1 and CD62P binding did not directly correlate with the platelet size and RP, %. In ITP patients with severe bleeding, the platelet count was lower, PAC-1 and CD62P binding was reduced and PA-IgG and RP, % levels were increased. Thus, a decrease in the content of activation markers on the platelet surface was registered in ITP patients; it was more pronounced in patients with severe bleeding. It is suggested that the cause of this decrease may be due to the effect of autoantibodies (PA-IgG) on platelets, and in particular on GP IIb-IIIa.<\/jats:p>","DOI":"10.18097\/pbmcr1596","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T07:28:34Z","timestamp":1756970914000},"page":"288-299","source":"Crossref","is-referenced-by-count":0,"title":["Platelet functional activity in patients with immune thrombocytopenia"],"prefix":"10.18097","volume":"71","author":[{"given":"V.V.","family":"Bodrova","sequence":"first","affiliation":[{"name":"Chazov National Medical Research Center of Cardiology, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.G.","family":"Khaspekova","sequence":"additional","affiliation":[{"name":"Chazov National Medical Research Center of Cardiology, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.N.","family":"Shustova","sequence":"additional","affiliation":[{"name":"Chazov National Medical Research Center of Cardiology, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.V.","family":"Tsvetaeva","sequence":"additional","affiliation":[{"name":"National Medical Research Center of Hematology, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.V.","family":"Mazurov","sequence":"additional","affiliation":[{"name":"Chazov National Medical Research Center of Cardiology, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7443","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Despotovic J.M., Bussel J.B. (2019) Immune Thrombocytopenia (ITP). In: Platelets, 4th ed. (Michelson A.D., Cattaneo M., Frelinger A.L., Newman P.J., eds., Academic Press, pp. 707\u2013724.","DOI":"10.1016\/B978-0-12-813456-6.00039-4"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Provan D., Donald M., Arnold D.M., Bussel J.B., Chong B.H., Cooper N., Gernsheimer T., Ghanima W., Godeau B., Gonz\u00e1lez-L\u00f3pez T.J., Grainger J., Hou M., Kruse C., McDonald V., Michel M., Newland A.C., Pavord S., Rodeghiero F., Scully M., Tomiyama Y., Wong R.S., Zaja F., Kuter D.J. (2019) Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv., 3(22), 3780\u20133817.","DOI":"10.1182\/bloodadvances.2019000812"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Carballeira D., Bernardo \u00c1., Caro A., Soto I., Guti\u00e9rrez L. (2024) Pathophysiology, clinical manifestations and diagnosis of immune thrombocytopenia: contextualization from a historical perspective. Hematol. Rep., 16(2), 204\u2013219.","DOI":"10.3390\/hematolrep16020021"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Neunert C., Noroozi N., Norman G., Buchanan G.R., Goy J., Nazi I., Kelton J.G., Arnold D.M. (2015) Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J. Thromb. Haemost., 13(3), 457\u2013464.","DOI":"10.1111\/jth.12813"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Psaila B., Bussel J.B., Frelinger A.L., Babula B., Linden M.D., Li Y., Barnard M.R., Tate C., Feldman E.J., Michelson A.D. (2011) Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia. J. Thromb. Haemost., 9(11), 2302\u20132310.","DOI":"10.1111\/j.1538-7836.2011.04506.x"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"van Bladel E.R., Laarhoven A.G., van der Heijden L.B., Heitink-Polle K.M., Porcelijn L., van der Schoot C.E., de Haas M., Roest M., Vidarsson G., de Groot P.G., Bruin M.C.A. (2014) Functional platelet defects in children with severe chronic ITP as tested with 2 novel assays applicable for low platelet counts. Blood, 123(10), 1556\u20131563.","DOI":"10.1182\/blood-2013-08-519686"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Frelinger A.L. 3rd, Grace R.F., Gerrits A.J., Berny-Lang M.A., Brown T., Carmichael S.L., Neufeld E.J., Michelson A.D. (2015) Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP. Blood, 126(7), 873\u2013879.","DOI":"10.1182\/blood-2015-02-628461"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Middelburg R.A., Carbaat-Ham J.C., Hesam H., Ragusi M.A.A.D., Zwaginga J.J. (2016) Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk. Hematology, 21(9), 549\u2013551.","DOI":"10.1080\/10245332.2016.1180097"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Frelinger A.L. 3rd, Grace R.F., Gerrits A.J., Carmichael S.L., Forde E.E., Michelson A.D. (2018) Platelet function in ITP, independent of platelet count, is consistent over time and is associated with both current and subsequent bleeding severity. Thromb. Haemost., 118(1), 143\u2013151.","DOI":"10.1160\/TH17-06-0387"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Panzer S., H\u00f6cker L., Rieger M., Vormittag R., Koren D., Dunkler D., Pabinger I. (2007) Agonist-inducible platelet activation in chronic idiopathic autoimmune thrombocytopenia. Eur. J. Haematol., 79(3), 198\u2013204.","DOI":"10.1111\/j.1600-0609.2007.00900.x"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Connor D.E., Ma D.D.F., Joseph J.E. (2013) Flow cytometry demonstrates differences in platelet reactivity and microparticle formation in subjects with thrombocytopenia or thrombocytosis due to primary haematological disorders. Thromb. Res., 132(5), 572\u2013577.","DOI":"10.1016\/j.thromres.2013.09.009"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Nishiura N., Kashiwagi H., Akuta K., Hayashi S., Kato H., Kanakura Y., Tomiyama Y. (2020) Reevaluation of platelet function in chronic immune thrombocytopenia: impacts of platelet size, platelet-associated anti-\u03b1IIb\u03b23 antibodies and thrombopoietin receptor agonist. Br. J. Haematol., 189(4), 760\u2013771.","DOI":"10.1111\/bjh.16439"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Ignatova A.A., Suntsova E.V., Pshonkin A.V., Martyanov A.A., Ponomarenko E.A., Polokhov D.M., Fedorova D.V., Voronin K.A., Kotskaya N.N., Trubina N.M., Krasilnikova M.V., Uzueva S.Sh., Serkova I.V., Ovsyannikova G.S., Romanova K.I., Hachatryan L.A., Kalinina I.I., Matveev V.E., Korsantiya M.N., Smetanina N.S., Evseev D.A., Sadovskaya M.N., Antonova K.S., Khoreva A.L., Zharkov P.A., Shcherbina A., Sveshnikova A.N., Maschan A.A., Novichkova G.A., Panteleev M.A. (2021) Platelet function and bleeding at different phases of childhood immune thrombocytopenia. Sci. Rep., 11, 9401.","DOI":"10.1038\/s41598-021-88900-6"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Skipper M.T., Rubak P., Stentoft J., Hvas A.-M., Larsen O.H. (2018) Evaluation of platelet function in thrombocytopenia. Platelets, 29(3), 270\u2013276.","DOI":"10.1080\/09537104.2017.1296566"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Psaila B., Bussel J.B., Linden M.D., Babula B., Li Y., Barnard M.R., Tate C., Mathur K., Frelinger A.L., Michelson A.D. (2012) In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation. Blood, 119(17), 4066\u20134072.","DOI":"10.1182\/blood-2011-11-393900"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Panzer S., Rieger M., Vormittag R., Eichelberger B., Dunkler D., Pabinger I. (2007) Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia. Eur. J. Clin. Invest., 37(10), 814\u2013819.","DOI":"10.1111\/j.1365-2362.2007.01855.x"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Bowles K.M., Cooke L.J., Richards E.M., Baglin T.P. (2005) Platelet size has diagnostic predictive value in patients with thrombocytopenia. Clin. Lab. Haematol., 27(6), 370\u2013373.","DOI":"10.1111\/j.1365-2257.2005.00726.x"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Kaito K., Otsubo H., Usui N., Yoshida M., Tanno J., Kurihara E., Matsumoto K., Hirata R., Domitsu K., Kobayashi M. (2005) Platelet size deviation width, platelet large cell ration, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia. Br. J. Haematol., 128(5), 698\u2013702.","DOI":"10.1111\/j.1365-2141.2004.05357.x"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Borkataky S., Jain R., Gupta R., Singh S., Krishan G., Gupta K., Kudesia M. (2009) Role of platelet volume indices in the differential diagnosis of thrombocytopenia: a simple and inexpensive method. Hematology, 14(3), 182\u2013186.","DOI":"10.1179\/102453309X426182"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Khaspekova S.G., Shustova O.N., Golubeva N.V., Vasiliev S.A., Mazurov A.V. (2015) Relationships of mean platelet volume and plasma thrombopoietin with glycocalicin levels in thrombocytopenic patients. Acta Haematol., 133(3), 295\u2013299.","DOI":"10.1159\/000362531"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Kienast J., Schmitz G. (1990) Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood, 75(1), 116-121.","DOI":"10.1182\/blood.V75.1.116.116"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Ault K.A., Rinder H.M., Mitchell J., Carmody M.B., Vary C.P., Hillman R.S. (1992) The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am. J. Clin. Pathol., 98(6), 637\u2013646.","DOI":"10.1093\/ajcp\/98.6.637"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Kurata Y., Hayashi S., Kiyoi T., Kosugi S., Kashiwagi H., Honda S., Tomiyama Y. (2001) Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia. Am. J. Clin. Pathol., 115(5), 656\u2013664.","DOI":"10.1309\/RAW2-0LQW-8YTX-941V"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Abe Y., Wada H., Sakakura M., Nishioka J., Tomatsu H., Hamaguchi Y., Oguni S., Shiku H., Nobori T. (2005) Usefulness of fully automated measurement of reticulated platelets using whole blood. Clin. Appl. Thromb. Hemost., 11(3), 263\u2013270.","DOI":"10.1177\/107602960501100304"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Bodrova V.V., Shustova O.N., Khaspekova S.G., Mazurov A.V. (2022) Platelet reticulated forms, size indexes and functional activity. Interactions in healthy volunteers. Platelets, 33(3), 398\u2013403.","DOI":"10.1080\/09537104.2021.1922659"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Rodeghiero F., Michel M., Gernsheimer T., Ruggeri M., Blanchette V., Busse J.B., Cines D.B., Cooper N., Godeau B., Greinacher A., Imbach P., Khellaf M., Klaassen R.J., K\u00fchne T., Liebman H., Mazzucconi M.G., Newland A., Pabinger I., Tosetto A., Stasi R. (2013) Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood, 121(14), 2596\u20132606.","DOI":"10.1182\/blood-2012-07-442392"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Khaspekova S.G., Shustova O.N., Golubeva N.V., Naimushin Y.A., Larina L.E., Mazurov A.V. (2019) Circulating antiplatelet antibodies in pregnant women with immune thrombocytopenic purpura as predictors of thrombocytopenia in the newborns. Platelets, 30(8), 1008\u20131012.","DOI":"10.1080\/09537104.2018.1557615"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Bierling P., Bettaieb A., Fromont P., Favrin M., Duedari N. (1994) Anti-GMP140 (CD62) autoantibody in a patient with autoimmune thrombocytopenic purpura. Br. J. Haematol., 87(3), 631\u2013633.","DOI":"10.1111\/j.1365-2141.1994.tb08327.x"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Bodrova V.V., Shustova O.N., Khaspekova S.G., Mazurov A.V. (2023) Laboratory markers of platelet production and turnover. Biochemistry (Moscow), 88(Suppl. 1), S39\u2013S51.","DOI":"10.1134\/S0006297923140031"}],"container-title":["Biomeditsinskaya Khimiya"],"original-title":[],"language":"ru","deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T07:28:53Z","timestamp":1756970933000},"score":1,"resource":{"primary":{"URL":"http:\/\/pbmc.ibmc.msk.ru\/en\/article-en\/PBMC-2025-71-4-288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.18097\/pbmcr1596","relation":{},"ISSN":["2310-6905","2310-6972"],"issn-type":[{"type":"electronic","value":"2310-6905"},{"type":"print","value":"2310-6972"}],"subject":[],"published":{"date-parts":[[2025]]}}}